logo
Man who 'would be dead' without charity appeals for donations amid funding shortfall

Man who 'would be dead' without charity appeals for donations amid funding shortfall

Yahoo5 days ago

A CUMBRIAN man who says he 'would have died' without the help of the air ambulance when he was involved in a brewery explosion last year has urged people to donate to the organisation.
The appeal comes following news that 2025 fundraising appeal for the vital Great North Air Ambulance Service has fallen behind target.
The charity, which provides life-saving care to critically ill and injured people across the North of England and the Isle of Man, relies on donations from the public to remain operational.
Unfortunately, their appeal, which helps fund the service, has failed to reach the same level of success as previous years.
Leigh Taylor, a 44-year-old from Seaton, was working on May 13, 2024, when he was engulfed by a fireball and badly burned in a blast at the Tractor Shed Brewery in Workington.
Speaking about how the air ambulance helped him that awful day, Leigh said: 'Last year I was involved in an accident at work, an explosion and I was in a critical condition, the air ambulance responded, air ambulance Doctor Patrick Duncan was the first one to respond, he responded in a vehicle and put me in an induced coma.
'I was flown to Newcastle RVI with 40% burns to my body; my legs, hands and face and they were basically the first link in the chain that saved my life that day.'
'I would have died; without a shadow of a doubt I would have died without them.
'I wouldn't have got to the RVI where they have a specialist burns unit, I wouldn't have got there in time on a road ambulance.'
In April, Leigh visited the GNAAS' base, where he had the opportunity to discuss his incident with Dr Duncan and find out more information about what happened in the aftermath.
Appealing to people to donate to the charity, Leigh said: 'I would just appeal to people to think (about donating). I had always given 5p in a charity bucket or something for the air ambulance always given loose change, but go and directly donate: five, ten, twenty pounds I would ask people to consider that because if you're like me you never know.
'You never think it's going to be you until it's you, I'd just ask people to spare a thought for that and give what they can to the air ambulance.'
It currently costs £9.3m a year to fund the service, which equates to just over £25,200 per day.
Joe Garcia, interim chief executive officer at GNAAS, said: 'The past few years have been challenging for GNAAS, and as time goes on, our aircraft are aging and the cost of running this service is increasing, whilst charitable support across all charities is dropping.
'In 2024 we were predicted to run at a deficit and go into our limited reserves just to keep us flying, and we don't want history to repeat itself.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Nearly 600 heat-related deaths expected in UK heatwave, researchers estimate
Nearly 600 heat-related deaths expected in UK heatwave, researchers estimate

Yahoo

timean hour ago

  • Yahoo

Nearly 600 heat-related deaths expected in UK heatwave, researchers estimate

Nearly 600 people in England and Wales are predicted to die as a result of this week's heatwave, researchers have found. Experts at the London School of Hygiene and Tropical Medicine (LSHTM) and Imperial College London used decades of UK data to predict excess mortality during the hot temperatures from Thursday to Sunday. Their study, released on Saturday, forecasts that around 570 people will die because of the heat over the four days. The excess deaths are estimated to peak at 266 on Saturday when the heat will be at its most intense. London is predicted to have the greatest number of excess deaths with 129. The researchers said their assessment highlights how extreme heat poses a growing threat to public health in the UK. It follows a World Weather Attribution (WWA) research group study published on Friday which found the heatwave has been made about 100 times more likely and 2-4C hotter due to climate change. Dr Garyfallos Konstantinoudis, lecturer at the Grantham Institute at Imperial College London, said: 'Heatwaves are silent killers – people who lose their lives in them typically have pre-existing health conditions and rarely have heat listed as a contributing cause of death. 'This real-time analysis reveals the hidden toll of heatwaves and we want it to help raise the alarm. 'Heatwaves are an underappreciated threat in the UK and they're becoming more dangerous with climate change.' Dr Konstantinoudis warned that people should follow heat-health advice this weekend and check on older people, particularly those living alone. Temperatures had been forecast to hit 32C across the South East on Saturday and had already reached that level on Thursday in London. The UK Health Security Agency issued an amber heat-health alert covering all of England to warn vulnerable populations of the health risks, including 'a rise in deaths'. Dozens of people required treatment for heat-related illness at Royal Ascot on Thursday. The researchers used findings from published research on the relationship between heat and the number of daily deaths, regardless of the cause, in 34,753 areas of England and Wales. They combined these with high-resolution weather forecasts from the Copernicus climate change service to estimate how many heat-related deaths will occur. They estimated that 114 excess deaths would have occurred on Thursday, 152 on Friday, 266 on Saturday and 37 deaths on Sunday, when temperatures will fall to the mid-20s. People above 65 are expected to be hardest hit, with 488 of the estimated excess deaths, the report said. But the experts also warn that heat can be life-threatening for all ages, with 82 deaths estimated for people aged under 65. They also note that the analysis does not account for the effect of the heatwave occurring early in summer before people are acclimatised to hot temperatures, meaning deaths could be underestimated. A recent report by the UK Climate Change Committee estimated that heat-related deaths could rise to more than 10,000 in an average year by 2050 if fossil fuel burning causes warming to reach 2C. UN scientists warned this week that the world is in 'crunch time' to limit warming and has three years left to prevent global average temperature rises exceeding 1.5C. Professor Antonio Gasparrini, of the LSHTM, said: 'Increases of just a degree or two can be the difference between life and death. 'Every fraction of a degree of warming will cause more hospital admissions and heat deaths, putting more strain on the NHS.' Dr Malcolm Mistry, assistant professor at the LSHTM, said: 'Exposure to temperatures in the high 20s or low 30s may not seem dangerous, but they can be fatal, particularly for people aged over 65, infants, pregnant people and those with pre-existing health conditions. 'Unless effective mitigation and adaptive measures are put in place in the coming years, the risk of large heat-related death events is set to increase in the UK – we have a large ageing population and warming is expected to increase to 2C by 2050 and as high as 3C this century.' Dr Lorna Powell, an NHS urgent care doctor in east London who was not involved in the study, said: 'We are seeing cases of heat-related illnesses rising in our urgent care departments. 'Heat exhaustion can quickly trigger more serious illnesses as dehydration sets in and the cardiovascular system becomes overwhelmed.'

KindlyMD Raises Another $51.5M for Bitcoin Treasury Strategy
KindlyMD Raises Another $51.5M for Bitcoin Treasury Strategy

Yahoo

time12 hours ago

  • Yahoo

KindlyMD Raises Another $51.5M for Bitcoin Treasury Strategy

KindlyMD (NAKA), a Salt Lake City-based health-care data firm merging with bitcoin-focused holding company Nakamoto, raised another $51.5 million for bitcoin BTC purchases, the companies announced Friday. The private placement equity financing round, also known as PIPE, was priced at $5 per share of common stock in KindlyMD. The financing was fully subscribed in less than three days, according to Nakamoto founder and CEO David Bailey. "We continue to execute our strategy to raise as much capital as possible to acquire as much bitcoin as possible," he said in a statement. This fundraising brings the firm's total capital raise to around $763 million, including previous PIPE financing and convertible notes offering. NAKA shares fell around 7% in the early Friday session. The Nasdaq Composite index was little changed. The move comes as a growing roster of public companies raise capital to create crypto treasury strategies, reminiscent of software firm Strategy's (MSTR) long-running play to issue debt and sell shares for purchasing digital assets. Strategy is the largest corporate bitcoin holder with 592,00 BTC, worth over $62 billion, data shows. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Cancer Concerns Spark Caution Over Weight Loss Injections
Cancer Concerns Spark Caution Over Weight Loss Injections

Medscape

time15 hours ago

  • Medscape

Cancer Concerns Spark Caution Over Weight Loss Injections

Cancer patients should seek medical advice before using weight loss injections, a leading UK charity has said. Macmillan Cancer Support urged patients not to view these drugs as 'quick fixes', following a rise in helpline queries over whether they should take them. Obesity is a well-established risk factor for several cancer types and is linked to worse outcomes in patients who already have a cancer diagnosis. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have seen rapid uptake for weight loss. Their popularity has helped fuel speculation that they could reduce the risk of cancer or improve outcomes in people with obesity-related cancers. Mixed Findings on Cancer Risk and Benefits A study published in The Lancet eClinical Medicine in May compared outcomes in patients treated with GLP-1 RAs versus bariatric surgery. The research involved 3178 age- and BMI-matched pairs in Israel. Despite surgery achieving greater weight loss, both groups had similar rates of obesity-related cancers. The researchers suggested that there could be additional pathways beyond weight loss through which GLP-1RAs might lower cancer risk, for example by reducing inflammation. Other experts have proposed additional pathways, including enhanced immune responses, improved insulin sensitivity, hormonal modulation, and changes to gut microbiome. As a result of the study, clinical trials of GLP-1RAs as potential anti-cancer agents are planned. Potential Risks: Thyroid and Pancreatic Cancer Some studies have suggested that GLP-1RAs carry a minor increase in the risk of thyroid cancer, which is one of the 13 cancers known to be linked with obesity. Some GLP-1RAs now carry warnings about this potential link, although the evidence is conflicting. One meta-analysis of 64 studies by Italian researchers, published in March 2024, found a significant increase overall thyroid cancer risk. However, the data did not show a significant rise in papillary or medullary thyroid cancer when analysed separately. The researchers concluded that GLP-1RA treatment could be associated with a moderate increase in the relative risk of thyroid cancer, though the absolute risk remained small. They called for longer-term studies to clarify the link. In contrast, a Scandinavian cohort study published in April found no substantial increase in thyroid cancer risk over an average follow-up of 3.9 years. The authors said the findings did not rule out a slight increase but suggested no more than a 31% relative risk rise. Similar concerns have been raised about a theoretical risk of pancreatic cancer, but no conclusive evidence has been found. Macmillan Helpline Sees Spike in Inquiries Following recent media coverage, Macmillan Cancer Support reported a surge in calls and messages about weight loss medications, including the potential risk to people with thyroid cancer. Dr Owen Carter, Macmillan's national clinical adviser, said in a press release that there had been "a noticeable increase" in calls to the charity's free support line, alongside "a flurry of messages" on its peer-to-peer online community platform. In response, the charity has published updated information about weight loss injections and cancer on its website. Carter said that some callers were concerned about taking weight loss drugs while undergoing cancer treatments such as chemotherapy or hormone therapy. While there is currently not enough evidence, "we do know that these drugs may affect how other drugs are absorbed by your body," he said. "This may include some anti-cancer drugs." Weight Loss Before Surgery and Pre-habilitation Other patients have asked whether weight loss medication is safe to take before surgery for cancer. "Understandably, people are keen to do what they can to get ready for cancer treatment," Carter said. Healthcare professionals often recommend pre-habilitation to help patients prepare for treatment by improving their fitness and overall health. However, Carter warned against unprescribed use of weight loss injections as 'quick fixes'. 'We simply do not know enough about the long-term impact of these weight loss medications to recommend them if they're not prescribed by a specialist,' he said. Carter also emphasised the importance of making lifestyle changes alongside use of medications. "We know that eating well and staying as active as possible are proven to help people feel better, increase their energy levels, and strengthen their immune systems, which can help them to manage their weight and cope better with cancer treatment", he said. Risks of Unregulated Online Purchases Macmillan also raised concerns about people buying GLP-1 RAs online from unregulated sources. Some patients are reported to have experienced severe side effects from counterfeit medicines. The charity urged people to speak to their GP before taking weight loss drugs. Macmillan noted that potential side-effects of GLP-1RAs include nausea and vomiting, abdominal pain, diarrhoea or constipation, and fatigue. They can also reduce the effectiveness of oral contraceptives. There have been reports of unplanned pregnancies occurring while taking these drugs, which may be particularly hazardous in cancer patients, as some cancer treatments are teratogenic.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store